Dark Forest Capital Management’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-27,314
Closed -$149K 1126
2024
Q2
$149K Buy
27,314
+14,430
+112% +$115K 0.03% 596
2024
Q1
$129K Buy
+12,884
New +$96.5K 0.02% 652
2023
Q2
Sell
-22,564
Closed -$73.8K 1351
2023
Q1
$73.8K Buy
22,564
+21,178
+1,528% +$84.6K 0.02% 757
2022
Q4
$5.47K Buy
1,386
+143
+12% +$699 ﹤0.01% 848
2022
Q3
$7K Sell
1,243
-276
-18% -$1.99K ﹤0.01% 830
2022
Q2
$10K Sell
1,519
-38,660
-96% -$246K ﹤0.01% 532
2022
Q1
$332K Buy
40,179
+39,028
+3,391% +$316K 0.08% 285
2021
Q4
$18K Buy
+1,151
New +$22.2K 0.01% 725

Other funds holding SANA

Dark Forest Capital Management's SANA Position: Q3 2024 in Review

Dark Forest Capital Management sold out of Sana Biotechnology (SANA) in Q3 2024, closing a stake of 27,314 shares — an estimated $149K sold.

Dark Forest Capital Management first reported a position in SANA in Q4 2021 and held it in 8 quarters. The position peaked at $332K in Q1 2022. 155 funds tracked by Wall St. Rank hold SANA as of Q3 2024.

  • Dark Forest Capital Management reported no remaining Sana Biotechnology position as of Q3 2024 after selling out during the quarter.
  • Dark Forest Capital Management sold 27,314 Sana Biotechnology shares in Q3 2024, an estimated $149K.
  • Dark Forest Capital Management first reported a position in Sana Biotechnology in Q4 2021 and held it in 8 quarters.
  • Dark Forest Capital Management's Sana Biotechnology position peaked at $332K in Q1 2022.
  • 155 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2024.

Based on Dark Forest Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.